Skip to main content
Fig. 5 | BMC Chemistry

Fig. 5

From: Synthesis, DFT and molecular docking of novel (Z)-4-bromo-N-(4-butyl-3 (quinolin-3-yl)thiazol-2(3H)-ylidene)benzamide as elastase inhibitor

Fig. 5

The comprehensive 2D fingerprint plots displaying all of the interactions involving compound 6 (a), which are separated into (b) H … H(44.1%), (c) H … C/C … H (15.3%), (d) H … Br/Br … H (8.4%), (e) H … O/O … H (6.7%), (f) H … S/S … H (6.3%), (g) C … C (5.6%), (h) H … N/N … H (4.9%), (i) C … Br/Br … C (4.0%), (j) C … N/N … C (2.5%), (k) S … Br/Br … S (0.6%), (l) N … Br/Br … N (0.5%), (m) O … Br/Br … O (0.4%), (n) N … S/S … N (0.4%), (o) C …S/S … C (0.2%) and (p) N … N (0.2%)

Back to article page